Streetbeat News

Analyst Ratings

PPBT

Purple Biotech (NASDAQ:PPBT) reported Q2 losses of $(0.25) per share, beating the analyst consensus estimate of $(0.26) by 3.85 percent. This represents a 225 percent decrease over earnings of $0.20 per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:33 pm

GPN

Truist Securities analyst Andrew Quail has maintained a 'Buy' rating on Global Payments (NYSE:GPN) and raised the price target from $145 to $160.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:32 pm

CPB

Jefferies analyst Rob Dickerson has maintained a 'Hold' rating on Campbell Soup (NYSE:CPB) and lowered the price target from $49 to $46.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:31 pm

PR

Truist Securities analyst Neal Dingmann maintains a 'Buy' rating on Permian Resources (NYSE:PR) and raises the price target from $16 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:30 pm

MO

Jefferies analyst Owen Bennett has maintained a 'Buy' rating on Altria Group (NYSE:MO) but lowered the price target from $56 to $55.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:29 pm

PM

Jefferies analyst Owen Bennett has maintained a 'Buy' rating on Philip Morris Intl (NYSE:PM) but lowered the price target from $113 to $111.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:28 pm

GEVO

Stifel analyst Derrick Whitfield has maintained a 'Buy' rating on Gevo (NASDAQ:GEVO) and raised the price target from $3 to $3.4.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:27 pm

TOL

Toll Brothers, Inc. (NYSE:TOL) is expected to report higher Q3 earnings at $2.81 per share, up from $2.35 per share a year ago. The company's revenue is projected to be $2.41 billion, compared to $2.26 billion in the year-ago period. Several analysts have recently adjusted their price targets for TOL, with the most bullish outlook coming from Raymond James, which upgraded the stock to a Strong Buy and set a price target of $100.

Portfolio Pulse from Lisa Levin

August 22, 2023 | 1:26 pm

DAR

Stifel analyst Derrick Whitfield has maintained a 'Buy' rating on Darling Ingredients (NYSE:DAR) but lowered the price target from $120 to $118.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:25 pm

CLNE

Stifel analyst Derrick Whitfield has maintained a 'Buy' rating on Clean Energy Fuels (NASDAQ:CLNE) and raised the price target from $6 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 1:25 pm